Partial Win Likely For Celgene In Mylan Antitrust Suit
A New Jersey federal judge indicated Wednesday that she would give Celgene Corp. a partial win in an antitrust suit from Mylan Pharmaceuticals Inc. over cancer drugs Thalomid and Revlimid, saying...To view the full article, register now.
Already a subscriber? Click here to view full article